IMPACT OF TYROSINE KINASE INHIBITORS ON MINIMAL RESIDUAL DISEASE AND OUTCOME IN CHILDHOOD PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

BACKGROUND: BCR-ABL1 tyrosine kinase inhibitors (TKIs) improve the outcome of childhood Philadelphia-chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) when incorporated into post-remission induction chemotherapy. No data is available on the impact of TKIs on end of induction minimal residua...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer
Main Authors: Jeha, Sima, Coustan-Smith, Elaine, Pei, Deqing, Sandlund, John T., Rubnitz, Jeffrey E., Howard, Scott C., Inaba, Hiroto, Bhojwani, Deepa, Metzger, Monika L., Cheng, Cheng, Choi, John K., Jacobsen, Jeffrey, Shurtleff, Sheila A., Raimondi, Susana, Ribeiro, Raul C., Pui, Ching-Hon, Campana, Dario
格式: Artigo
語言:Inglês
出版: 2014
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249731/
https://ncbi.nlm.nih.gov/pubmed/24501014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28598
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍